Epidemiology and treatment of fungal corneal ulcers

International Ophthalmology Clinics

Volumn 47, Issue 3, 2007, Pages 7-16

  Ou, Judy I ^a   Acharya, Nisha R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; CLOTRIMAZOLE; CONTACT LENS SOLUTION; CORTICOSTEROID; ECONAZOLE; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; KETOCONAZOLE; NATAMYCIN; POSACONAZOLE; PYRROLE DERIVATIVE; VORICONAZOLE;

ADJUVANT THERAPY; ASPERGILLUS; ATOPIC DERMATITIS; ATOPY; CANDIDA ALBICANS; CHINA; CLINICAL TRIAL; CONTACT LENS; CORNEA ULCER; DIABETES MELLITUS; DISEASE PREDISPOSITION; DRY EYE; FUSARIUM OXYSPORUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INDIA; INJURY; KERATOMYCOSIS; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SKIN DEFECT; SOUTH ASIA; UNITED STATES;

CORNEAL ULCER; EYE INFECTIONS, FUNGAL; HUMANS;

EID: 34547617876     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e318074e727     Document Type: Review

References (44)

1. Srinivasan M. Fungal keratitis. Curr Opin Ophthalmol. 2004;15:321-327.
2. Gonzales CA, Srinavasan M, Whitcher JP, et al. Incidence of corneal ulceration in Madurai district, South India. Ophthalmic Epidemiol. 1996;3:159-166.
3. Srinivasan M, Gonzales CA, George C, et al. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India. Br J Ophthalmol. 1997;81:965-971.
4. Upadhyay MP, Karmacharya PC, Koirala S, et al. Epidemiologic characteristics, predisposing factors, and etiologic diagnosis of corneal ulceration in Nepal. Am J Ophthalmol. 1991;111:92-99.
5. Gopinathan U, Garg P, Fernandes M, et al. The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India. Cornea. 2002;21:555-559.
6. Ormerod LD. Causation and management of microbial keratitis in subtropical Africa. Ophthalmology. 1987;94:1662-1668.
7. Xie L, Zhong W, Shi W, et al. Spectrum of fungal keratitis in north China. Ophthalmology. 2006;113:1943-1948.
8. Liesegang TJ, Forster RK. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol. 1980;90:38-47.
9. Asbell P, Stenson S. Ulcerative keratitis. Survey of 30 years' laboratory experience. Arch Ophthalmol. 1982;100:77-80.
10. Varaprasathan G, Miller K, Lietman T, et al. Trends in the etiology of infectious corneal ulcers at the F. I. Proctor Foundation. Cornea. 2004;23:360-364.
11. Rosa RH Jr, Miller D, Alfonso EC. The changing spectrum of fungal 2keratitis in south Florida. Ophthalmology. 1994;101:1005-1013.
12. Ritterband DC, Seedor JA, Shah MK, et al. Fungal keratitis at the New York eye and ear infirmary. Cornea. 2006;25:264-267.
13. Tanure MA, Cohen EJ, Sudesh S, et al. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea. 2000;19:307-312.
14. Bharathi MJ, Ramakrishnan R, Vasu S, et al. Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study. Indian J Ophthalmol. 2003;51:315-321.
15. Chowdhary A, Singh K. Spectrum of fungal keratitis in North India. Cornea. 2005;24:8-15.
16. Wilhelmus KR, Robinson NM, Font RA, et al. Fungal keratitis in contact lens wearers. Am J Ophthalmol. 1988;106:708-714.
17. Alfonso EC, Cantu-Dibildox J, Munir WM, et al. Insurgence of Fusarium keratitis associated with contact lens wear. Arch Ophthalmol. 2006;124:941-947.
18. Khor WB, Aung T, Saw SM, et al. An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. JAMA. 2006;295:2867-2873.
19. Bernal MD, Acharya NR, Lietman TM, et al. Outbreak of Fusarium keratitis in soft contact lens wearers in San Francisco. Arch Ophthalmol. 2006;124:1051-1053.
20. Chang DC, Grant GB, O'Donnell K, et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA. 2006;296:953-963.
21. Chung MS, Goldstein MH, Driebe WT, et al. Fungal keratitis after laser in situ keratomileusis: a case report. Cornea. 2000;19:236-237.
22. Muallem MS, Alfonso EC, Romano AC, et al. Bilateral Candida parapsilosis interface keratitis after laser in situ keratomileusis. J Cataract Refract Surg. 2003;29:2022-2025.
23. Kouyoumdjian GA, Forstot SL, Durairaj VD, et al. Infectious keratitis after laser refractive surgery. Ophthalmology. 2001;108:1266-1268.
24. Wright TM, Afshari NA, et al. Microbial keratitis following corneal transplantation. Am J Ophthalmol. 2006;142:1061-1062.
25. O'Day DM. Selection of appropriate antifungal therapy. Cornea. 1987;6:238-245.
26. Manzouri B, Vafidis GC, Wyse RK. Pharmacotherapy of fungal eye infections. Expert Opin Pharmacother. 2001;2:1849-1857.
27. O'Day DM, Head WS, Robinson R, et al. Corneal penetration of topical amphotericin B and natamycin. Curr Eye Res. 1986;5:877-882.
28. Prajna NV, John RK, Nirmalan PK, et al. A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis. Br J Ophthalmol. 2003;87:1235-1237.
29. Kalavathy CM, Parmar P, Kaliamurthy J, et al. Comparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitis. Cornea. 2005;24:449-452.
30. O'Day DM, Ray WA, Robinson RD, et al. In vitro and in vivo susceptibility of Candida keratitis to topical polyenes. Invest Ophthalmol Vis Sci. 1987;28:874-880.
31. Thomas PA. Current perspectives on ophthalmic mycoses. Clin Microbiol Rev. 2003;16:730-797.
32. O'Day DM. Fungal keratitis. In: Holland KWGN, Wilhelmus KR, eds. Ocular Infection and Immunology. St Louis: Mosby; 1996:1048-1061.
33. Mselle J. Use of topical clotrimazole in human keratomycosis. Ophthalmologica. 2001;215:357-360.
34. Hariprasad SM, Mieler WF, Holz ER, et al. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol. 2004;122:42-47.
35. Marangon FB, Miller D, Giaconi JA, et al. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol. 2004;137:820-825.
36. Denning DW, Ribaud P, Milpied N, et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis. 2002;34:563-571.
37. Ozbek Z, Kang S, Sivalingam J, et al. Voriconazole in the management of Alternaria keratitis. Cornea. 2006;25:242-244.
38. Bunya VY, Hammersmith KM, Rapunano CJ, et al. Topical and oral voriconazole in the treatment of fungal keratitis. Am J Ophthalmol. 2007;143:151-153.
39. Lalitha P, Shapiro BL, Srinavasian M, et al. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Ophthalmology. 2007. In press.
40. Xie L, Dong X, Shi W. Treatment of fungal keratitis by penetrating keratoplasty. Br J Ophthalmol. 2001;85:1070-1074.
41. Chen WL, Wu CY, Hu FR, et al. Therapeutic penetrating keratoplasty for microbial keratitis in Taiwan from 1987 to 2001. Am J Ophthalmol. 2004;137:736-743.
42. Xie L, Zhai H, Shi W. Penetrating keratoplasty for corneal perforations in fungal keratitis. Cornea. 2007;26:158-162.
43. Lee SH, Tseng SC. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol. 1997;123:303-312.
44. Chen HC, Tan HY, Hsiao CH, et al. Amniotic membrane transplantation for persistent corneal ulcers and perforations in acute fungal keratitis. Cornea. 2006;25:564-572.